<?xml version="1.0" encoding="UTF-8"?>
<p id="Par112">A randomized, blinded, healthy control pilot trial of non-invasive transcutaneous vagal stimulation reported downregulation of inflammatory cytokine release [
 <xref ref-type="bibr" rid="CR106">106</xref>]. Clinical trials of non-invasive vagal stimulation in COVID-19 are currently under way (NCT04382391, NCT04379037).
</p>
